Small Molecules
17 March 2015
Zydus launches SoviHep – the breakthrough therapy for Hepatitis C in alliance with Gilead Sciences17 March 2015
Phase 3 Study with IMBRUVICA® (ibrutinib) Combination Demonstrates Significant Delay in Disease Progression17 March 2015
Actavis Receives FDA Approval for VIIBRYD® (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose13 March 2015
AB Science : Positive Phase 2 Clinical Study Data of Masitinib in Triple Negative Breast Cancer12 March 2015
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Announce Completion of a Pharmacokinetics Study on CL-10812 March 2015
Concert Pharmaceuticals Initiates Phase 1 Trial Evaluating Deuterated Ivacaftor for Cystic Fibrosis11 March 2015
Trevi Therapeutics Announces Initiation of a Pivotal Study of Nalbuphine ER in Prurigo Nodularis10 March 2015
Alcobra’s MDX Meets Primary Endpoint in Phase II Safety and Tolerability Clinical Trial in Adolescents With ADHD10 March 2015
Viamet Announces Initiation of RENOVATE Phase 2b Study of Oral VT-1161 in OnychomycosisNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports